Clinical Trial Update: Lonquek for Autologous Stem Cell Mobilization [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Lonquek in autologous stem cell mobilization across lymphoma and multiple myeloma (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Lonquek

Snippet

Sponsor: Sheba Medical Center | Conditions: Lymphoma, Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN